{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-03",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "city": "Beaumont",
      "advisory_committee_description": "Immunology",
      "address_1": "1530 Lindbergh Dr.",
      "address_2": "",
      "statement_or_summary": "Statement",
      "product_code": "OBZ",
      "openfda": {
        "registration_number": [
          "1618982",
          "8023024"
        ],
        "fei_number": [
          "6387",
          "1618982"
        ],
        "device_name": "Alpha-1-Antitrypsin Kit, Qualitative Phenotype",
        "medical_specialty_description": "Immunology",
        "regulation_number": "866.5130",
        "device_class": "2"
      },
      "zip_code": "77707",
      "applicant": "Helena Laboratories, Corp.",
      "decision_date": "2022-10-13",
      "decision_code": "SESE",
      "country_code": "US",
      "device_name": "SPIFE A1AT kit",
      "advisory_committee": "IM",
      "contact": "Rachel  Easley",
      "expedited_review_flag": "",
      "k_number": "K213396",
      "state": "TX",
      "date_received": "2021-10-18",
      "review_advisory_committee": "IM",
      "postal_code": "77707",
      "decision_description": "Substantially Equivalent",
      "clearance_type": "Traditional"
    }
  ]
}